| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7B | $3.0B | $3.5B | $3.9B | $2.3B | $2.0B | $2.8B | $2.6B |
| Cost of Revenue | $0.0B | $0.0B | $0.1B | $0.2B | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B |
| Operating Income | $0.3B | $0.6B | $1.0B | $1.6B | $0.3B | $-1.4B | $0.4B | $0.6B |
| Net Income | $0.0B | $0.1B | $0.1B | $0.2B | $0.2B | $-0.2B | $-0.1B | $0.1B |
| EPS (Basic) | $0.08 | $0.35 | $0.76 | $1.28 | $1.09 | $-1.11 | $-0.71 | $0.60 |
| EPS (Diluted) | $0.08 | $0.34 | $0.75 | $1.26 | $1.09 | $-1.11 | $-0.47 | $0.59 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.8B | $9.7B | $9.8B | $10.3B | $10.3B | $10.6B | $11.7B | $11.1B |
| Current Assets | $0.8B | $0.8B | $0.8B | $1.0B | $0.9B | $1.0B | $1.0B | $0.9B |
| Cash & Equivalents | $0.4B | $0.4B | $0.3B | $0.5B | $0.5B | $0.3B | $0.3B | $0.4B |
| Total Liabilities | $4.6B | $4.3B | $4.2B | $5.2B | $6.0B | $6.2B | $5.9B | — |
| Current Liabilities | $1.1B | $0.9B | $0.8B | $1.3B | $1.2B | $0.7B | $0.9B | $0.8B |
| Stockholders' Equity | $5.1B | $5.2B | $5.4B | $5.0B | $4.2B | $4.2B | $5.5B | $4.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | — | — | — | — | $1.4B | $0.8B | $1.5B | $1.2B |
| Investing Cash Flow | $-1.0B | $-0.9B | $-1.0B | $-1.1B | $-0.4B | $-0.9B | $-2.5B | $-1.9B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.3B | $-0.7B | $-0.9B | $-1.1B | $-0.8B | $0.0B | $-1.1B | $0.1B |